Clinical Trial Update: SLV308 for Treatment of Patients With Parkinson's Disease Experiencing Motor Fluctuations [Phase 3]

View source ↗

Summary

The update notes that a Phase 3 trial of SLV308 in patients with advanced Parkinson's disease experiencing motor fluctuations has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• SLV308

Snippet

Sponsor: Solvay Pharmaceuticals | Conditions: Advanced Stage Parkinson's Disease | Phase 3 | Status: COMPLETED